Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains

Methods in Molecular Biology

Volumn 797, Issue , 2012, Pages 127-140

  Diallo, Jean Simon ^a   Vähä Koskela, Markus ^a   Le Boeuf, Fabrice ^a   Bell, John ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Neutralizing antibodies; Oncolytic; Purification; Syngeneic mouse model; Vesicular stomatits virus

Indexed keywords

MEMBRANE PROTEIN; MUTANT PROTEIN;

ANIMAL; ARTICLE; BLOOD; EXPERIMENTAL NEOPLASM; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MOUSE; ONCOLYTIC VIROTHERAPY; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS VIRUS; VIRUS CULTURE; VIRUS REPLICATION;

ANIMALS; GENETIC VECTORS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MUTANT PROTEINS; NEOPLASMS, EXPERIMENTAL; ONCOLYTIC VIROTHERAPY; SIGNAL TRANSDUCTION; VESICULOVIRUS; VIRUS CULTIVATION; VIRUS REPLICATION;

VESICULAR STOMATITIS VIRUS;

EID: 80555135981     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-340-0_10     Document Type: Chapter

References (12)

1. Rose, J., Whitt, M. (2001) Rhabdoviridae: The viruses and Their Replication, 4th ed., Lippincott Williams and Wilkins, New York.
2. Lichty, B. D., Power, A. T., Stojdl, D. F., and Bell, J. C. (2004) Vesicular stomatitis virus: re-inventing the bullet. Trends Mol Med 10, 210–6.
3. Stojdl, D. F., Lichty, B., Knowles, S., Marius, R., Atkins, H., Sonenberg, N., and Bell, J. C. (2000) Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 6, 821–5.
4. Stojdl, D. F., Lichty, B. D., tenOever, B. R., Paterson, J. M., Power, A. T., Knowles, S., Marius, R., Reynard, J., Poliquin, L., Atkins, H., Brown, E. G., Durbin, R. K., Durbin, J. E., Hiscott, J., and Bell, J. C. (2003) VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4, 263–75.
5. Obuchi, M., Fernandez, M., and Barber, G. N. (2003) Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity. J Virol 77, 8843–56.
6. Segura, M. M., Garnier, A., and Kamen, A. (2006) Purification and characterization of ret-rovirus vector particles by rate zonal ultracen-trifugation. J Virol Methods 133, 82–91.
7. Cantin, R., Diou, J., Belanger, D., Tremblay, A. M., and Gilbert, C. (2008) Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J Immunol Methods 338, 21–30.
8. Le Boeuf, F., Diallo, J. S., McCart, J. A., Thorne, S., Falls, T., Stanford, M., Kanji, F., Auer, R., Brown, C. W., Lichty, B. D., Parato, K., Atkins, H., Kirn, D., and Bell, J. C. (2010) Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing. Mol Ther 18 (5), 888–95.
9. Nguyen, T. L., Abdelbary, H., Arguello, M., Breitbach, C., Leveille, S., Diallo, J. S., Yasmeen, A., Bismar, T. A., Kirn, D., Falls, T., Snoulten, V. E., Vanderhyden, B. C., Werier, J., Atkins, H., Vaha-Koskela, M. J., Stojdl, D. F., Bell, J. C., and Hiscott, J. (2008) Chemical targeting of the innate antiviral response by his-tone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis. Proc Natl Acad Sci USA 105, 14981–6.
10. Parato, K. A., Senger, D., Forsyth, P. A., and Bell, J. C. (2005) Recent progress in the battle between oncolytic viruses and tumours. Nat Rev Cancer 5, 965–76.
11. Stanford, M. M., Breitbach, C. J., Bell, J. C., and McFadden, G. (2008) Innate immunity, tumor microenvironment and oncolytic virus therapy: friends or foes? Curr Opin Mol Ther 10, 32–7.
12. Ikeda, K., Ichikawa, T., Wakimoto, H., Silver, J. S., Deisboeck, T. S., Finkelstein, D., Harsh, G. R., Louis, D. N., Bartus, R. T., Hochberg, F. H., and Chiocca, E. A. (1999) Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Nat Med 5, 881–7.